ANDERSON, S.C.-Tactical Medical Solutions, LLC (“TacMed”), a leading innovator and manufacturer of proprietary pre-hospital medical components and technology for tactical and civilian applications, and Guardian Capital Partners, announce the acquisition of TraumaFX Solutions, Inc. (“TFX”).
TraumaFX is the global market leader in innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations. TFX specializes in high-fidelity, rugged simulators that deliver the most lifelike experience for trainees while enabling field exercise in any environment and weather condition.
TraumaFX’s innovative platform, with its advanced sensor technology, monitors critical treatment procedures and wirelessly transmits data to trainers so instruction can be optimized in real-time. After-action reporting provides objective feedback to leaders and staff confirming competencies, capabilities, and readiness.
“With a growing need to deliver trauma response capabilities in many environments, the addition of TraumaFX provides our customers a continuum of capabilities, from training support to market leading products, that will enhance their ability to respond when required,” said Ross Johnson, TacMed CEO. “Tactical Medical Solutions’ mission is to lead in trauma response and minimize preventable death. That starts with training and ensuring responders have access to life-saving medical technology. We are pleased to add TraumaFX to our portfolio as nothing on the market creates a more realistic and effective training environment than the TFX product line. We know it will support our clients’ efforts to deliver on their critical mission.”
Tactical Medical Solutions, LLC (TacMed) is a global leader in the development and manufacture of innovative, proprietary pre-hospital medical products and technologies that serve a full spectrum of emergency response environments. Routed in the belief that our clients should have better than we did, our products have been developed to support the critical mission of enabling trauma response in both civilian and military markets.
With over 2000 products in more than 70 countries, TacMed provides high quality trauma response solutions for all levels of first responders, backed by accreditations from organizations including the US Department of Defense, the Committee on Tactical Combat Casualty Care, and the American Red Cross. TacMed products have been selected by elite military forces around the world, 7 of the top 10 law enforcement agencies, major metropolitan police, fire & EMS agencies across the globe, and in public access venues including professional sports stadiums, international hotel chains, airports, churches, museums, scholastic institutions, and numerous other civilian arenas.
In emergency settings, minutes matter, and TacMed is honored to support those that serve the critical mission of trauma response.
Additional information available at: www.tacmedsolutions.com
TraumaFX is dedicated to developing innovative medical simulation and training technologies that improve survivability of severe injuries on the battlefield and in civilian casualty situations. We specialize in high-fidelity, ruggedized medical patient simulators to deliver the most lifelike experience for trainees while enabling field exercises in any environment and in any weather condition. Our advanced sensor technology monitors and records critical treatment procedures and immediately transmits data to trainers wirelessly to optimize instruction in real-time. After-action reporting data provides objective feedback to leaders about staff capabilities and readiness.
Originally developed under a research and development contract with the U.S. Army ARL-STTC, TraumaFX today offers a broad portfolio of human and canine medical simulators that allow military personnel, first responders, K9 handlers, veterinarians, and emergency medical professionals to experience the complexities of treating severe injuries, properly and effectively, in real world situations.
Additional information available at: www.traumafx.net